MeSH term
Frequency | Condition_Probility | Cell Cycle | 3 | 0.0 |
Female | 12 | 0.0 |
*Gene Expression Profiling | 3 | 0.0 |
Humans | 52 | 0.0 |
Amino Acid Chloromethyl Ketones/pharmacology | 4 | 3.0 |
Animals | 24 | 0.0 |
Apoptosis/physiology | 2 | 0.0 |
Caspases/antagonists & inhibitors | 2 | 4.0 |
Enzyme Inhibitors/pharmacology | 3 | 0.0 |
*Membrane Proteins | 15 | 1.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
*Proto-Oncogene Proteins c-bcl-2 | 4 | 0.0 |
Research Support, Non-U.S. Gov't | 36 | 0.0 |
Tumor Cells, Cultured | 14 | 0.0 |
Mice | 14 | 0.0 |
Proteasome Endopeptidase Complex | 2 | 0.0 |
Transcription, Genetic/physiology | 2 | 1.0 |
*Adaptor Proteins, Signal Transducing | 2 | 0.0 |
Cells, Cultured | 5 | 0.0 |
*Mitochondrial Proteins | 2 | 1.0 |
Proto-Oncogene Proteins c-bcl-2/*genetics | 2 | 2.0 |
Research Support, U.S. Gov't, P.H.S. | 18 | 0.0 |
Adult | 4 | 0.0 |
Comparative Study | 6 | 0.0 |
Genes, bcl-2 | 4 | 3.0 |
Protein Biosynthesis | 3 | 0.0 |
Proteins/genetics | 7 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Time Factors | 6 | 0.0 |
Transcription, Genetic/drug effects | 2 | 0.0 |
Aged | 2 | 0.0 |
Apoptosis/genetics | 3 | 1.0 |
Combined Modality Therapy | 2 | 0.0 |
Middle Aged | 4 | 0.0 |
Tissue Distribution | 3 | 0.0 |
Caspases/metabolism | 2 | 0.0 |
Antineoplastic Agents/*pharmacology | 3 | 0.0 |
Apoptosis/*drug effects/physiology | 3 | 2.0 |
Tumor Cells, Cultured/*drug effects/metabolism | 2 | 7.0 |
Amino Acid Sequence | 9 | 0.0 |
Cytochrome c Group/metabolism | 6 | 4.0 |
Hela Cells | 3 | 0.0 |
Molecular Sequence Data | 10 | 0.0 |
Protein Conformation | 2 | 0.0 |
Proteins/metabolism | 2 | 0.0 |
Proto-Oncogene Proteins c-bcl-2/metabolism | 3 | 0.0 |
Rats | 6 | 0.0 |
Rats, Inbred Strains | 2 | 0.0 |
Recombinant Proteins/metabolism | 3 | 0.0 |
Transfection | 12 | 0.0 |
Amino Acid Motifs | 2 | 0.0 |
*Apoptosis | 14 | 0.0 |
Blotting, Northern | 5 | 0.0 |
Blotting, Western | 7 | 0.0 |
Cell Death | 3 | 0.0 |
Cell Line | 12 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Gene Library | 2 | 0.0 |
Microscopy, Confocal | 2 | 0.0 |
Microscopy, Fluorescence | 3 | 0.0 |
Models, Genetic | 2 | 0.0 |
Precipitin Tests | 5 | 0.0 |
Protein Binding | 2 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Cysteine Proteinase Inhibitors/pharmacology | 2 | 0.0 |
Jurkat Cells | 2 | 0.0 |
Mutation | 3 | 0.0 |
Phosphorylation | 2 | 0.0 |
Apoptosis/*genetics | 3 | 1.0 |
Base Sequence | 4 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Gene Expression | 3 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Proteins/*genetics | 3 | 0.0 |
Antigens, CD95/genetics | 2 | 8.0 |
*Gene Expression Regulation | 2 | 0.0 |
*Genes, bcl-2 | 3 | 4.0 |
HL-60 Cells | 2 | 0.0 |
Membrane Proteins/genetics | 2 | 0.0 |
Proto-Oncogene Proteins/genetics | 3 | 0.0 |
Apoptosis/*drug effects | 4 | 0.0 |
Cell Division/drug effects | 2 | 0.0 |
Gene Expression Regulation, Neoplastic/*drug effects | 2 | 0.0 |
Genes, p53 | 2 | 0.0 |
*Tumor Suppressor Proteins | 2 | 0.0 |
Male | 7 | 0.0 |
Protein Structure, Secondary | 3 | 0.0 |
Apoptosis | 3 | 0.0 |
Endothelial Growth Factors/genetics | 2 | 2.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Dimerization | 3 | 0.0 |
Proto-Oncogene Proteins c-bcl-2/*physiology | 2 | 8.0 |
Binding Sites | 2 | 0.0 |
Membrane Proteins/*metabolism | 5 | 1.0 |
Proteins/genetics/*metabolism | 2 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 2 | 0.0 |
*Mutation | 2 | 0.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Cell Line, Tumor | 6 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
Apoptosis/*physiology | 5 | 0.0 |
Conserved Sequence | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
*Caspases | 2 | 3.0 |
Enzyme Activation | 4 | 0.0 |
Gene Expression Regulation, Neoplastic/drug effects | 2 | 0.0 |
Mitochondria/metabolism | 3 | 1.0 |
Sequence Deletion | 2 | 0.0 |
Genes, Dominant | 2 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Models, Biological | 2 | 0.0 |
Antineoplastic Agents/pharmacology | 2 | 0.0 |
Histone Deacetylases/antagonists & inhibitors | 2 | 4.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Flow Cytometry | 3 | 0.0 |
Gene Therapy/*methods | 2 | 0.0 |
Mice, Nude | 4 | 0.0 |
Xenograft Model Antitumor Assays | 2 | 0.0 |
Up-Regulation | 2 | 0.0 |
Membrane Potentials | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
Subcellular Fractions/metabolism | 2 | 0.0 |
Genetic Vectors | 2 | 0.0 |
Neoplasm Proteins/*genetics | 2 | 0.0 |
English Abstract | 2 | 0.0 |
Caspases/*metabolism | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
Immunoblotting | 2 | 0.0 |
